Study guide
26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK)
IJCAHPO Certified Ophthalmic Medical Technologist COMT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements
1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification
2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology
2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway
3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety
3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety
4 Chapter 4: Ophthalmic History Taking & Clinical Documentation
4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record
5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision
5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction
6 Chapter 6: Tonometry, Keratometry & Pupil Measurement
6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria
7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis
7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment
8 Chapter 8: Refraction, Retinoscopy & Refinement
8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations
9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics
9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations
10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy
10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training
11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation
11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing
12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique
12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics
13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials
14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)
14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics
15 Chapter 15: Fluorescein Angiography Principles & Technique
15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management
16 Chapter 16: Angiographic Interpretation & Pathology
16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology
17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography
17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers
18 Chapter 18: Ophthalmic Photography & Videography
18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management
19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)
19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging
20 Chapter 20: Biometry, Topography & Corneal Analysis
20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth
21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting
21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems
22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications
22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis
23 Chapter 23: Ocular Pharmacology
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF
24 Chapter 24: Microbiology & Ocular Specimen Collection
24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection
25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery
25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery
26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol
27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures
27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)
28 Chapter 28: Ophthalmic Patient Services & Education
28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support
29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance
29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements
26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK)
Key Takeaways Explain This Topic AI
Penetrating keratoplasty (PKP) is a full-thickness corneal transplantation that replaces all five anatomical layers, secured with 10-0 nylon sutures (interrupted, continuous running, or combined), with the donor button routinely oversized by 0.25 to 0.50 mm relative to the host bed to prevent flat anterior chambers and high hyperopia.
Corneal graft rejection is anatomically categorized into epithelial (fluorescein-positive migratory line), subepithelial (Krachmer spots), stromal, and endothelial rejection; endothelial rejection is the most devastating form, characterized by keratic precipitates aligned along a progressing Khodadoust line.
Deep Anterior Lamellar Keratoplasty (DALK) replaces the diseased stroma down to Descemet's membrane (typically via the big-bubble pneumodissection technique) while preserving the host's native healthy endothelium, virtually eliminating the risk of endothelial graft rejection.
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) transplants donor posterior stroma, Descemet's membrane, and endothelium (~100–150 µm), whereas Descemet Membrane Endothelial Keratoplasty (DMEK) transplants bare Descemet's membrane and endothelium (~10–15 µm) without stroma, yielding superior 20/20 visual acuity and dramatically lower rejection rates (<1%–2%).
Endothelial graft adherence in DSAEK and DMEK relies on an anterior chamber air or 20% SF₆ gas bubble tamponade and strict post-operative supine positioning; graft detachments involving >1/3 of the lenticule or the visual axis necessitate prompt anterior chamber rebubbling.
Last updated: September 2026
Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK)
Core Clinical Mandate: Modern corneal surgery has transitioned from full-thickness penetrating keratoplasty (PKP) to targeted lamellar transplantation, replacing only the pathologically diseased anatomical layer while preserving healthy host tissue. Ophthalmic medical technologists must thoroughly understand donor trephination mechanics, suturing geometries, immunological graft rejection lines, and the microsurgical techniques of DALK, DSAEK, and DMEK.
Penetrating Keratoplasty (PKP): Full-Thickness Transplantation
Penetrating Keratoplasty (PKP) involves the full-thickness, 5-layer excision of a central button of diseased host cornea and its replacement with a full-thickness, clear donor corneal graft. It is indicated when pathology involves both anterior/stromal and posterior/endothelial layers (e.g., full-thickness corneal scars, advanced keratoconus with acute hydrops scars, severe infectious keratitis with perforation, combined stromal and endothelial dystrophies, or trauma). Five Anatomical Layers Replaced in Full-Thickness PKP:
- [1. Epithelium] ──► [2. Bowman's Layer] ──► [3. Stroma (90% thickness)]
- ──► [4. Descemet's Membrane] ──► [5. Endothelium (Monolayer)]
- Trephination Sizing Principles: The Oversizing Rationale
The recipient host bed is cut using a circular suction trephine (e.g., Barron vacuum trephine, Hessburg-Barron, or Hanna trephine) or a femtosecond laser. The donor button is punched from the endothelial side using a guided donor punch.
Standard Donor Oversizing (+0.25 mm to +0.50 mm):
In standard clinical practice, the donor graft punch is selected to be 0.25 mm to 0.50 mm larger in diameter than the recipient trephination aperture (e.g., cutting a 7.50 mm recipient bed and punching a 7.75 mm or 8.00 mm donor button ).
Prevention of Shallow / Flat Anterior Chamber: An oversized graft provides additional tissue redundancy, facilitating watertight, tension-free closure. A same-sized graft placed under high suture tension tends to pull taut like a flat drumhead, shallowing the anterior chamber and causing peripheral anterior synechiae (PAS).
Prevention of Secondary Glaucoma: Flat anterior chambers and tight wounds crowd the iridocorneal drainage angle. Oversizing deepens the anterior chamber angle and preserves trabecular outflow, dramatically reducing post-operative intraocular pressure spikes.
Refractive Control (Prevention of Severe Hyperopia): An oversized donor button increases the anterior curvature (steepness) of the transplanted cornea. Corneas transplanted with same-size buttons flatten post-operatively, causing massive hyperopic refractive shifts (+5.00 to +10.00 D) that require thick spectacles or contact lens correction.
Same-Size Trephination (0.0 mm Oversize):
Occasionally utilized in patients with extreme pre-existing axial myopia (> -8.00 D) to deliberately flatten the central cornea and decrease myopic refractive error. However, this carries a significantly higher risk of wound leak, flat anterior chamber, and angle closure.
Suture Geometries, Tensioning & Knot Burial
Corneal donor buttons are secured using 10-0 nylon (monofilament elastic suture with high tensile strength) mounted on sharp, spatulated side-cutting micro-needles. Suture bites must penetrate to approximately 90% of corneal stromal depth (just anterior to Descemet's membrane). Full-thickness penetration into the anterior chamber creates a conduit for aqueous leakage, microbial entry, and infectious endophthalmitis, while shallow bites (<75% depth) cause internal wound gaping, posterior wound sliding, and severe irregular astigmatism.
Suture Pattern Advantages Disadvantages Primary Clinical Indications
Interrupted Sutures (16 to 24 sutures) Allows selective suture removal to treat high post-op astigmatism; safe in inflamed/vascularized beds More surface knots; longer operating time; unequal tensioning Inflamed, vascularized, infected, pediatric, or trauma corneas
Continuous Running Suture (Single 16-bite or double continuous) Smooth optical surface; less patient foreign-body sensation; reduced neovascularization Broken suture causes catastrophic total wound dehiscence; cannot selectively remove Young non-inflamed corneas, keratoconus, elective uninflamed PKP
Combined (Interrupted + Running) Dual security: running suture provides rapid watertight seal; interrupted sutures maintain tectonic stability Technical complexity; requires two-stage suture management Standard elective PKP balancing early rehabilitation and safety
Knot Burial Protocol: Every suture knot must be rotated and buried completely into either the host stroma or the donor stroma (away from the limbus). Exposed nylon knots attract mucus, induce giant papillary conjunctivitis (GPC), promote corneal neovascularization, and serve as a nidus for microbial colonization and devastating infectious stitch abscesses.
Loading diagram... Corneal Transplantation Decision Matrix: Full-Thickness vs. Selective Lamellar
Immunology of Corneal Graft Rejection & The Khodadoust Line
The normal cornea is an immunologically privileged site due to several physiological factors: absence of vascular and lymphatic vessels (afferent and efferent immune limb blockade), expression of immunosuppressive molecules (Fas ligand, CD95L, TGF-beta), and anterior chamber-associated immune deviation (ACAID). However, when host-donor human leukocyte antigens (HLA class I and II) are recognized by recipient CD4+ and CD8+ T-lymphocytes, an immune-mediated allograft rejection episode is triggered.
Corneal graft rejection is strictly categorized by the anatomical layer under immunological attack:
1. Epithelial Rejection
Clinical Manifestation: Presents as an elevated, irregular, migratory linear ridge of degenerating donor epithelial cells that stains brightly with fluorescein. The line originates near a vascularized graft border and sweeps across the donor surface over several days, leaving normal host epithelium behind.
Prognosis: Mildest form of rejection. Readily reversible with topical corticosteroids. Because host epithelium eventually replaces donor epithelium, epithelial rejection does not cause permanent graft failure unless accompanied by endothelial rejection.
2. Subepithelial Rejection (Krachmer Spots)
Clinical Manifestation: Presents as discrete, round, subepithelial infiltrates confined exclusively to the donor button, identical in morphology to the nummular infiltrates seen in adenoviral epidemic keratoconjunctivitis (EKC). These lesions are termed Krachmer spots and represent focal lymphocytic inflammatory aggregates situated immediately beneath Bowman's layer.
3. Stromal Rejection
Clinical Manifestation: Presents with full-thickness or mid-stromal haze, circumscribed stromal edema, and deep stromal vascularization extending across the graft-host junction. It is frequently accompanied by conjunctival ciliary injection and anterior chamber cell and flare.
4. Endothelial Rejection: The Khodadoust Line
Clinical Significance: The most common, critical, and visually devastating form of rejection. Unlike epithelium, human corneal endothelial cells have virtually zero mitotic regenerative capacity ( G 1 G_1 G 1 cell cycle arrest). If endothelial cells are destroyed by cytotoxic T-cells, permanent corneal decompensation, bullous keratopathy, and irreversible graft failure ensue.
Pathognomonic Sign: The Khodadoust Line:
Named after Iranian-American ophthalmologist Ali Khodadoust.
Appears on slit lamp examination as an irregular, elevated, white line composed of inflammatory mononuclear leukocytes and keratic precipitates (KPs) marching along the posterior surface of the donor endothelium.
The Khodadoust line almost always originates at a peripheral vascularized graft segment and advances centrally across the donor endothelium .
The Danger Zone: Ahead of the advancing line, the donor cornea remains relatively compact and clear. Behind the advancing Khodadoust line, the endothelium has been destroyed , leaving severe full-thickness stromal and epithelial edema.
Emergency Therapeutic Intervention: Requires immediate, high-frequency topical pulse corticosteroids: prednisolone acetate 1% or difluprednate 0.05% every 1 hour , supplemented with subconjunctival steroid injections or high-dose intravenous methylprednisolone pulse therapy (500 mg to 1 g) for fulminant rejections.
Deep Anterior Lamellar Keratoplasty (DALK): Preserving Endothelium
Deep Anterior Lamellar Keratoplasty (DALK) is an advanced partial-thickness corneal procedure that removes the recipient's diseased corneal epithelium, Bowman's layer, and 95% to 100% of the stroma down to the pre-Descemet layer (Dua's layer) and Descemet's membrane, while preserving the patient's native, healthy Descemet's membrane and endothelium .
Major Clinical Indications
DALK is indicated for any corneal pathology where the endothelium is completely healthy:
Keratoconus (without prior history of acute corneal hydrops, which tears Descemet's membrane).
Stromal Corneal Dystrophies (Lattice, Granular, Macular, Avellino dystrophies).
Superficial and Mid-Stromal Scars (post-traumatic, post-infectious, healed bacterial or fungal ulcers).
Corneal Ectasia following LASIK or PRK.
The "Big-Bubble" Technique (Anwar Technique)
The critical surgical challenge in DALK is cleanly separating the deep posterior stroma from Descemet's membrane without perforating the gossamer-thin (10–12 µm) Descemet membrane: Anwar Big-Bubble Cleavage Sequence:
- [Partial Trephination ~80% Depth] ──► [Insert 27G/30G Bent Needle into Deep Stroma]
- ──► [Air Injection] ──► [Cleavage: Pre-Descemet Plane Forms 'Big Bubble']
- ──► [Stromal Debulking into 4 Quadrants] ──► [Suture Donor Stroma to Bare Host DM]
Partial Trephination: The host cornea is trephined to approximately 75% to 80% stromal depth.
Needle Insertion: A 27-gauge or 30-gauge bent needle (or specialized blunt DALK cannula) is advanced through the paracentral stroma into the deepest pre-Descemet posterior stroma.
Pneumodissection ("The Big Bubble"): Air is forcefully injected. The pressurized air creates a pneumatic cleavage plane that strips Descemet's membrane away from the posterior stroma, forming a circular, glistening, dome-shaped air bubble (type 1 bubble separating Dua's layer, or type 2 bubble separating bare Descemet's membrane).
Stromal Debulking: The anterior and posterior stroma overlying the big bubble is divided into four quadrants with micro-scissors and excised, exposing a pristine, crystal-clear host Descemet's membrane.
Graft Suture: A donor button (stripped completely of its own donor Descemet's membrane and endothelium) is placed into the host bed and secured with 10-0 nylon sutures.
Unmatched Clinical Advantages of DALK over PKP
Zero Risk of Endothelial Rejection: Because the patient retains their native endothelium, true endothelial graft rejection (Khodadoust line and endothelial cell destruction) is biologically impossible . Patients can only experience mild, easily treatable epithelial or stromal rejection.
Closed-System Tectonic Safety: Because the anterior chamber is never opened (in non-perforated cases), the devastating "open-sky" risks of PKP—specifically expulsive suprachoroidal hemorrhage and vitreous prolapse—are completely eliminated.
Shorter Steroid Regimens: Topical corticosteroids can be tapered and discontinued much earlier than in PKP, drastically reducing the incidence of steroid-induced secondary open-angle glaucoma and posterior subcapsular cataracts.
Superior Globe Tectonic Strength: Retaining the native Descemet's membrane and peripheral stroma preserves structural ocular integrity against blunt traumatic rupture.
Endothelial Lamellar Keratoplasty: DSAEK vs. DMEK
When corneal pathology is restricted exclusively to the endothelial monolayer and Descemet's membrane (e.g., Fuchs Endothelial Corneal Dystrophy [FECD] , Pseudophakic Bullous Keratopathy [PBK] , posterior polymorphous corneal dystrophy, or failed prior graft endothelium), replacing the entire cornea with PKP is obsolete. Instead, Endothelial Keratoplasty (EK) selectively replaces the diseased endothelium and Descemet's membrane through small, self-sealing clear corneal incisions (3.0 to 5.0 mm).
DSAEK (Descemet Stripping Automated Endothelial Keratoplasty)
Donor Tissue Architecture: Donor tissue is prepared in an eye bank or operating room using an automated microkeratome. The resulting lenticule consists of donor posterior stroma, Descemet's membrane, and endothelium . Standard DSAEK lenticule thickness ranges between 100 µm and 150 µm (Ultra-Thin DSAEK [UT-DSAEK] is refined to <100 µm , typically 70–90 µm).
Surgical Execution:
Host Descemetorhexis: Under air or viscoelastic, the host's diseased central Descemet's membrane and dysfunctional endothelium (with guttae) are scored and stripped across an 8.0 mm zone ( descemetorhexis ) using a reverse-bent hook (Sinskey or Price hook) and removed from the anterior chamber.
Lenticule Insertion: The donor lenticule is loaded onto a glide system (e.g., Busin glide, Tan EndoGlide) or taco-folded (60/40 endothelial fold) with cohesive viscoelastic and pulled/injected into the anterior chamber through a 4.0 mm corneal or scleral incision.
Unfolding & Tamponade: The donor lenticule unfolds easily due to the structural stiffness provided by the donor stromal carrier layer. A full anterior chamber air bubble is injected to press the lenticule firmly against the stripped host stroma.
DMEK (Descemet Membrane Endothelial Keratoplasty)
Donor Tissue Architecture: Represents true anatomical replacement. The donor tissue consists exclusively of bare Descemet's membrane and endothelium (~10 to 15 µm thick) with zero donor stroma .
Donor Peeling & Spontaneous Scrolling: Bare Descemet's membrane is stripped manually from donor rim stroma using fine forceps. Because of the elastic physical properties of Descemet's membrane, once stripped of stroma, it spontaneously rolls up like a tight scroll ( the DMEK roll ), with the endothelial monolayer oriented on the outside of the scroll.
Orientation Marking: To prevent inverted ("upside-down") insertion—which results in immediate primary graft failure—the stromal side of the membrane is stamped with an asymmetric vital dye mark (e.g., an "S-stamp" or peripheral triangle notches). Correct orientation confirms the stamp reads correctly from the anterior approach.
Insertion & Non-Touch Unscrolling: The tightly curled DMEK roll is aspirated into a specialized glass cartridge (e.g., Straiko or Jones tube) and injected into the anterior chamber through a tiny 2.4 to 2.8 mm clear corneal incision. Unscrolling is achieved using gentle, indirect fluidic waves and external corneal tapping (the "DAP" [Dirisamer-Aquavella-Parker] technique) without ever touching the fragile donor endothelium directly.
DSAEK vs. DMEK: Comparative Clinical Metrics
- Parameter DSAEK (Standard) DMEK (Pure Membrane)
- Transplanted Layers Posterior stroma + Descemet + Endothelium Descemet's membrane + Endothelium ONLY
- Graft Thickness 100 to 150 µm (UT-DSAEK <100 µm) 10 to 15 µm
- Visual Acuity Outcomes 20/40 average; only ~20–30% achieve ≥20/25 ≥85% achieve ≥20/25; ~50% achieve 20/20
- Higher-Order Aberrations Induced stromal interface haze & scatter Near-zero interface scatter; crisp optics
Refractive Shift Induces +1.00 to +1.50 D hyperopic shift (thicker periphery acts as minus lens) Neutral / Minimal refractive shift (~ +0.25 D)
Allograft Rejection Rate ~8% to 10% at 2 to 5 years <1% to 2% (lowest of all keratoplasties)
Learning Curve Moderate; lenticule is stiff and easily manipulated Steep; fragile scroll requires fluidic unscrolling
- Rebubbling Rate Low (approximately 3% to 5% ) Moderate to High (approximately 10% to 20% )
- Tamponade Bubbles, Post-Operative Supine Positioning & Rebubbling
Because lamellar endothelial grafts do not utilize sutures, initial graft adherence depends entirely on the mechanical buoyant force of an anterior chamber gas or air bubble:
Tamponade Agents: The anterior chamber is filled with sterile air or 20% sulfur hexafluoride (SF₆) gas (which lasts 7 to 10 days, providing longer tamponade for DMEK).
Mandatory Strict Supine Positioning: The patient must maintain a strict, flat supine (face-up) posture for 24 to 48 hours post-operatively (lying flat in bed looking straight at the ceiling). The floating bubble presses the endothelial lenticule upward against the host stroma, allowing endothelial cellular pump function to dehydrate the interface and establish permanent biological adherence.
Pupillary Block Prevention: A full 100% gas fill can wedge the iris forward against the trabecular meshwork, causing acute pupillary block glaucoma. To prevent this, the surgeon routinely performs an inferior peripheral iridotomy/iridectomy (PI) at 6 o'clock before gas injection, and dilates the pupil post-operatively, leaving a partial fluid meniscus inferiorly.
Rebubbling Protocol: If slit-lamp biomicroscopy or anterior segment OCT (AS-OCT) reveals graft detachment exceeding one-third (33%) of the graft area or any detachment crossing the central visual axis, the patient must undergo prompt rebubbling . Under topical anesthesia at the slit lamp or in the operating room, an anterior chamber paracentesis is tapped to release fluid, and sterile air or 20% SF₆ is reinjected to re-appose the detached lenticule.